MYLAN 2250 MYLAN 2250 (Mycophenolate Mofetil 250 mg)
Pill with imprint MYLAN 2250 MYLAN 2250 is Tan / Purple, Capsule-shape and has been identified as Mycophenolate mofetil 250 mg. It is supplied by Mylan Pharmaceuticals Inc..
Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; autoimmune hepatitis; bullous pemphigoid; graft-versus-host disease (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN 2250 MYLAN 2250
- MYLAN 2250 MYLAN 2250
- 250 mg
- Tan / Purple
- 19.00 mm
- Prescription only
- Drug Class:
- Selective immunosuppressants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
FD&C Blue No. 2
ferric oxide red
ferric oxide yellow
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
|NDC Code||Labeler / Repackager|
|51079-0721||UDL Laboratories Inc.|
More about mycophenolate mofetil
- Mycophenolate mofetil Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 44 Reviews
- Drug class: selective immunosuppressants
- Mycophenolate mofetil oral/injection
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Injection Solution
- Mycophenolate Mofetil Oral Suspension
- Mycophenolate Mofetil Tablets
- ... +2 more
Other brands: CellCept
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.